Shanghai Medicilon Inc. (SHA:688202)
73.22
+1.69 (2.36%)
At close: Jul 31, 2026
Shanghai Medicilon Employees
Shanghai Medicilon had 2,504 employees as of December 31, 2025. The number of employees increased by 155 or 6.60% compared to the previous year.
Employees
2,504
Change
155
Growth
6.60%
Revenue / Employee
503.44K CNY
Profits / Employee
-54.98K CNY
Market Cap
9.63B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,504 | 155 | 6.60% |
| Dec 31, 2024 | 2,349 | -251 | -9.65% |
| Dec 31, 2023 | 2,600 | -698 | -21.16% |
| Dec 31, 2022 | 3,298 | 858 | 35.16% |
| Dec 31, 2021 | 2,440 | 798 | 48.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Chengzhi | 4,462 |
| Nanjing Vazyme Biotech | 3,002 |
| Pacific Shuanglin Bio-pharmacy | 2,755 |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 2,360 |
| Vcanbio Cell & Gene Engineering Corp., | 1,935 |
| Jiangxi Fushine Pharmaceutical | 1,663 |
| GemPharmatech | 1,590 |
| Beijing Hotgen Biotech | 946 |